cy 208-243 has been researched along with Parkinson Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guillén, J; Laguna, J; Luquin, MR; Martínez-Lage, JM; Obeso, JA | 1 |
| Agid, Y; Emre, M; Lataste, X; Lees, A; Rascol, A; Rinne, UK | 1 |
| Durrieu, G; Lataste, X; Montastruc, JL; Rascol, A; Rascol, O; Senard, JM; Tran, MA | 1 |
| Agid, Y; Bonnet, AM; Jenner, PG; Lataste, X; Markstein, R; Marsden, CD; Pourcher, E; Quinn, NP; Temlett, JA | 1 |
| Calne, DB; Peppard, RF; Tsui, JK; Wolters, EC | 1 |
2 trial(s) available for cy 208-243 and Parkinson Disease
| Article | Year |
|---|---|
Effects of a selective partial D1 agonist, CY 208-243, in de novo patients with Parkinson disease.
Topics: Adult; Aged; Antiparkinson Agents; Bromocriptine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Indoles; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Phenanthridines; Receptors, Dopamine; Receptors, Dopamine D1 | 1992 |
A double-blind, placebo-controlled, dose-ranging study to investigate the safety and efficacy of CY 208-243 in patients with Parkinson's disease.
Topics: Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Phenanthridines; Placebos | 1989 |
3 other study(ies) available for cy 208-243 and Parkinson Disease
| Article | Year |
|---|---|
The AMPA receptor antagonist NBQX does not alter the motor response induced by selective dopamine agonists in MPTP-treated monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Dopamine Agents; Excitatory Amino Acid Antagonists; Ibotenic Acid; Indoles; Macaca fascicularis; Motor Activity; Oxazines; Parkinson Disease; Phenanthridines; Quinoxalines; Receptors, AMPA; Receptors, Glutamate | 1993 |
Blood pressure and plasma catecholamines in never-treated parkinsonian patients: effect of a selective D1 agonist (CY 208-243).
Topics: Antiparkinson Agents; Atropine; Blood Pressure; Epinephrine; Female; Heart Rate; Humans; Indoles; Male; Middle Aged; Norepinephrine; Parkinson Disease; Phenanthridines; Posture; Reference Values | 1990 |
Antiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Analgesics; Animals; Callitrichinae; Dopamine Agents; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Phenanthridines; Pyridines | 1989 |